Hermann Amschler

Title: Hermann Amschler: Innovator in Therapeutic Compounds

Introduction

Hermann Amschler is a notable inventor based in Constance, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds. His work focuses on creating innovative solutions for various medical conditions.

Latest Patents

Amschler holds a patent for "Therapeutic piperazinylalkyl-quinazolone-(4)-derivatives." This patent describes aryl-substituted piperazinylalkyl-quinazolone-(4) derivatives that are suitable for use as hypotensive, antihistaminic, and analgesic drugs. The patent outlines a process for preparing these compounds through several methods, including intra molecular condensation and reactions involving halogen-alkyl quinazolone and aryl piperazine. Additionally, it discloses pharmaceutical compositions containing these compounds and halogenalkanoic acid-6-carbamyl anilides useful for their preparation.

Career Highlights

Amschler is associated with Byk Gulden Lomberg Chemische Fabrik Gesellschaft mit beschränkter Haftung, where he has contributed to the advancement of pharmaceutical research and development. His innovative approach has led to the creation of valuable therapeutic agents that address critical health issues.

Collaborations

Throughout his career, Amschler has collaborated with esteemed colleagues, including Wolfgang Schoetensack and Kurt Klemm. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic solutions.

Conclusion

Hermann Amschler's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare. His work continues to influence the development of effective therapeutic agents.